216 related articles for article (PubMed ID: 10971510)
1. Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy.
Wakelkamp IM; Gerding MN; Van Der Meer JW; Prummel MF; Wiersinga WM
Clin Exp Immunol; 2000 Sep; 121(3):453-7. PubMed ID: 10971510
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking.
Salvi M; Pedrazzoni M; Girasole G; Giuliani N; Minelli R; Wall JR; Roti E
Eur J Endocrinol; 2000 Aug; 143(2):197-202. PubMed ID: 10913938
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy.
Hofbauer LC; Mühlberg T; König A; Heufelder G; Schworm HD; Heufelder AE
J Clin Endocrinol Metab; 1997 Jul; 82(7):2244-7. PubMed ID: 9215301
[TBL] [Abstract][Full Text] [Related]
4. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.
Shen J; Li Z; Li W; Ge Y; Xie M; Lv M; Fan Y; Chen Z; Zhao D; Han Y
Dis Markers; 2015; 2015():609593. PubMed ID: 26089587
[TBL] [Abstract][Full Text] [Related]
5. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
[TBL] [Abstract][Full Text] [Related]
6. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease.
Kallmann BA; Hüther M; Tubes M; Feldkamp J; Bertrams J; Gries FA; Lampeter EF; Kolb H
Diabetes; 1997 Feb; 46(2):237-43. PubMed ID: 9000700
[TBL] [Abstract][Full Text] [Related]
7. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
Tang L; Luo Q; Zhou X; Xia R
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
[TBL] [Abstract][Full Text] [Related]
8. [Autoantibodies, immunoglobulins and cytokine profile in patients with graves' disease and Graves' orbitopathy].
Sviridenko NY; Bessmertnaya EG; Belovalova IM; Mikheenkov AA; Sheremeta MS; Nikankina LV; Malysheva NM
Probl Endokrinol (Mosk); 2020 Oct; 66(5):15-23. PubMed ID: 33369369
[TBL] [Abstract][Full Text] [Related]
9. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
10. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.
Wakelkamp IM; Bakker O; Baldeschi L; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2003 Mar; 58(3):280-7. PubMed ID: 12608932
[TBL] [Abstract][Full Text] [Related]
11. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
Molnár I
Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
[TBL] [Abstract][Full Text] [Related]
12. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?
Rostoker G; Rymer JC; Bagnard G; Petit-Phar M; Griuncelli M; Pilatte Y
Clin Exp Immunol; 1998 Dec; 114(3):468-76. PubMed ID: 9844059
[TBL] [Abstract][Full Text] [Related]
13. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.
Mühlberg T; Heberling HJ; Joba W; Schworm HD; Heufelder AE
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998
[TBL] [Abstract][Full Text] [Related]
14. Study on IL-1alpha, IL-1beta and sIL-1ra in sera of patients with Graves' ophthalmopathy.
Liu G; Wu Z; Yang H; Lin Z; Chen T; Liang Y; Huang X; Wu H
Yan Ke Xue Bao; 2002 Sep; 18(3):151-5. PubMed ID: 15510744
[TBL] [Abstract][Full Text] [Related]
15. Cytokines serum levels as the markers of thyroid activation in Graves' disease.
Komorowski J; Jankiewicz J; Robak T; Błasińska-Morawiec M; Stepień H
Immunol Lett; 1998 Feb; 60(2-3):143-8. PubMed ID: 9557956
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
[TBL] [Abstract][Full Text] [Related]
18. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
[TBL] [Abstract][Full Text] [Related]
19. Serum pro- and anti-inflammatory cytokines in patients with Graves' disease with ophthalmopathy during treatment with glucocorticoids.
Myśliwiec J; Kretowski A; Szelachowska M; Mikita A; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():160-9. PubMed ID: 10697431
[TBL] [Abstract][Full Text] [Related]
20. Th1/Th2 cytokines in patients with Graves' disease with or without ophthalmopathy.
Esfahanian F; Naimi E; Doroodgar F; Jadali Z
Iran J Allergy Asthma Immunol; 2013 May; 12(2):168-75. PubMed ID: 23754356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
